Fig. 6.1 An illustration of how traditional approaches to pelvic floor dysfunctions have been segmented according to disciplines and pelvic compartments There is a common agreement that many problems or…
The key players and their involvements are displayed below. Items which concern mainly preoperative care are highlighted in green. Items which concern mainly intra-operative care are highlighted in yellow. Items…
Nomogram (PLND type) used to derive % risk of finding positive LNs at RP Low risk patient: cT1c, PSA 2.5, Gleason 3 + 3, 3/12 positive cores (%) Intermed. Risk patient :…
1. WG1, Handling of Radical Prostatectomy Specimens. R Montironi (Chair), H Samaratunga, L True 2. WG2, pT2 substaging and tumour volume in prostatectomy specimens. T Van der Kwast (Chair), M…
Fig. 7.1 Open retropubic radical prostatectomy: Incision of the prostatic apex Fig. 7.2 Prostatic bed after removal of the prostate 7.3 Radical Prostatectomy: Oncological Results Today there are several consolidated…
Risk classification Stage PSA Gleason Low risk T1-2a ≤10 ng/ml ≤6 Intermediated risk T2b >10 and ≤ 20 ng/ml 7 High risk T2c-3a >20 ng/ml ≥ 8 This system uses PSA level, Gleason grade, and…
Fig. 6.1 MR images of a 63-year-old patient with prostate-specific antigen (PSA) progression from 3.8 ng/mL (2012) to 4.9 ng/mL (2013). (a) High-resolution axial T2-weighted fast spin-echo image showing a focal hypointense…
Fig. 10.1 Proposed spiral model for prostate cancer progression by Logothetis [8] According to this model, the transition from endocrine to paracrine-driven prostate cancer is associated with a number of…
Parameter Value Age (years) 67.6 ± 8.5 (69), 46–76 Total PSA (ng/ml) 6.9 ± 23.2 (3.5), 0.003–146.0 Familiarity 24 (16.3) Gleason score ≤7(3 + 4) 115 (78) ≥7(4 + 3) 32 (22) Staging Localised 95 (65) Locally advanced…
Fig. 8.1 Choline PET/CT images of a 69-year-old patient with biochemical recurrence (PSA serum level 2.3 ng/ml) after radical prostatectomy for prostate cancer. (a) Axial coronal fused PET/CT image showing an…
